Prof @CedarsSinai making drugs safer 1B data points at a time. @Stanford BMI PhD; @Columbia DBMI; @tatonetti.bsky.social; EiC BioData Mining; he/they šŸ³ļøā€šŸŒˆ

Los Angeles, CA
Joined December 2008
Another year of amazing bioinformatics and biomedical AI and another Year-in-Review. Was a great time at AMIA's Amplify 2026 conference. The slides are here for anyone that wants them, complete with accompanying Spotify playlist. tatonettilab-resources.s3.am…
1
2
8
586
Nicholas Tatonetti retweeted
Instead of paying hundreds of thousands of dollars for a """doctor""" to take an X-Ray, you can get one for free from ChatGPT. My hand has been hurting like hell lately, but it turns out it's totally fine!
427
1,147
1,002
35,487
5,121,582
Nicholas Tatonetti retweeted
Clinical LLMs learn from EHR data not found in pretraining, but training them is expensive & they go stale as general models improve. We introduce CAPT, which steers a general model w/ a clinical model at inference (even w/ diff tokenizers!) Led by the stellar @SashaRonaghi šŸ‘‡
Check out our paper ā€œTraining-Free Adaptation of New-Generation LLMs using Legacy Clinical Modelsā€ recently presented at @CHILconference
2
31
4,196
Nicholas Tatonetti retweeted
CEOs walking into work after realizing that the AI tokens are going to cost more than the employees they fired
173
1,208
109
16,578
794,356
It's time again for the AMIA Translational Bioinformatics Year-in-Review This year: 2k papers triaged, 600+ reviewed. The final set is wild. Foundation models, multimodal bio, spatial everything, generative proteins, and some pure brain candy. Can't wait to present! #Amplify2026
9
360
Nicholas Tatonetti retweeted
I’m looking forward to hosting a conversation with leaders from @bmsnews and @TempusAI about a challenge that continues to come up in oncology: too many patients still face barriers to the testing and treatments that could help them most. Register here: tempus.co/4vSbDw2
3
4
7
1,377
OnSIDES v3.1.1 is out! šŸŽ‰ Updated with drug labels through April 2026 from all four sources (US, UK, EU, Japan): - 41K+ product labels - 6.9M drug–adverse event pairs - 4,097 ingredients Also fixes some bugs — if you're using that., please upgrade. github.com/tatonetti-lab/ons…
2
194
GI fellow Jamil Samaan noticed something odd when using AI ambient scribes and speech transcription tools Clinicians with non-native English accents appeared to confuse the model He and Yassi Fatapour decided to investigate, now out in npj Digital Medicine nature.com/articles/s41746-0…
1
2
1
5
1,085
Some patterns stood out 1) the gap was largest in base Whisper with ~11 point higher word error rates for non-native speakers 2) errors clustered in clinically dense language 3) more biomedical terminology > higher error rates - medication/disease names were especially vulnerable
1
118
We then tested a simple correction pipeline: WhisperX transcription → LLM correction Passing transcripts through an LLM told to ā€œadjust the errorsā€ reduced word error rates by ~4.5–6.9 pts This also narrowed the gap between groups nature.com/articles/s41746-0…
79
who's going to point it their epic instance?
CLAUDE CODE but for HACKING its called shannon, you point it at website and it just... tries to break in... fully autonomous with no human needed i pointed it at a test app and it stole the entire user database, created admin accounts, and bypassed login, all by itself, in 90 minutes
323
Training our LLMs to be sycophants has real consequences, especially in healthcare. When are models are overconfident, we all suffer. Check out our editorial here link.springer.com/article/10…
1
2
291
Nicholas Tatonetti retweeted
AlphaGenome is our latest & most advanced genomics model published in @Nature today including making the model & weights available to academic researchers. Can’t wait to see what the research community will do with it. Congrats to the team on our newest front cover! #AI4Science
Our breakthrough AI model AlphaGenome is helping scientists understand our DNA, predict the molecular impact of genetic changes, and drive new biological discoveries. 🧬 Find out more in @Nature ↓ goo.gle/4bXlV6y
121
657
47
4,725
505,953
Nicholas Tatonetti retweeted
The largest randomized trial of medical A.I. —Over 100,000 women in Sweden —radiologist + AI vs 2 radiologists, in follow-up —AI added led to 29% more cancer detected, 44% reduced workload, and —Less cancer dx in subsequent 2 years, and, when found, less aggressive thelancet.com/journals/lance…
110
1,280
217
5,874
1,503,485
Excited to announce our new project with ARPA-H which advances methods to artificially accelerate the aging of organoids to study drug toxicities over time. A current huge gap in our understanding and our models. cedars-sinai.org/newsroom/ce…
1
2
10
3,265
Nicholas Tatonetti retweeted
After twelve years of work, the world’s most beautiful subway station has been inaugurated in Rome: Colosseo, an underground archaeological museum.
197
1,037
110
7,954
558,011
Nicholas Tatonetti retweeted
Replying to @DrSamuelBHume
Another modern miracle in our lifetime
7
100
11
550
27,975
Nicholas Tatonetti retweeted
This paper is wild. After 3 rounds of directed evolution, they converted a DNA polymerase into an enzyme that can do: - RNA synthesis - Reverse transcription - Synthesis of "unnatural" nucleotides - Synthesis of DNA-RNA chimeras One of the best papers I’ve read recently. For context: In nature, it is DNA polymerase that takes a DNA sequence as a template and then copies it. These enzymes are crucial in replicating the genome for cell division, and they are EXTREMELY specific for DNA over RNA. This is key because RNA nucleotides are present in the cell at concentrations ~100x higher than DNA nucleotides, so the enzyme has evolved clever strategies to select one over the other. RNA polymerases, for comparison, are the enzymes that take a DNA sequence as template and then convert it into RNA. They are involved in gene expression, for example. To convert a DNA polymerase into an RNA polymerase (and all the other functions I mentioned earlier), the authors did a fairly straightforward directed evolution experiment. First, they took four DNA polymerase enzymes belonging to various archaea. These DNA polymerases don’t check for DNA vs. RNA as stringently as other types of cells, so they’re a good starting point to evolve RNA polymerases. The authors inserted some targeted mutations into these enzymes, based on known mutations in the literature. For example, they swapped the amino acid at position 409 for a smaller amino acid, thus removing a ā€œgateā€ that keeps RNA building blocks from entering the enzyme. Next, they took the four genes encoding these DNA polymerases and cut them up into 12 segments each. They randomly stitched these 12 segments together — from the four different genes — to build millions of unique variants. Each shuffled gene was inserted into an E. coli cell. Then, they grew up these cells (each carrying a unique polymerase) and put them into microfluidic droplets. A device isolates each droplet, lyses the cell open, and releases the polymerase. The droplet also contains RNA building blocks and a DNA template, encoding a fluorescent reporter. If the polymerase begins synthesizing RNA, it will produce a detectable signal. They screened about 100 million droplets in 10 hours of work, searching for those with a signal. For each well that yields a fluorescent signal, the researchers isolated the DNA and sequenced it to figure out which polymerase it was. They repeated this 3x times, finally isolating a really excellent RNA polymerase variant which they called "C28." C28 has 39 mutations compared to the wildtype enzymes. It incorporates about 3.3 nucleotides of RNA per second, with 99.8% fidelity. The crazy thing is that this enzyme can also copy DNA or RNA templates back into DNA (reverse transcription), or use chimeric DNA-RNA molecules as a template and amplify them. It is just a super versatile polymerase that can act on DNA, RNA, or modified nucleotides, to build just about anything.
17
349
28
1,661
87,241